How often are Medicare Advantage imaging prior authorization denials overturned?
As of November 2026, Medicare Advantage imaging prior authorization appeals refer to second-level reviews of denied CT, MRI, PET and CT angiography requests, which an October 2026 study found are overturned 20.5% of the time at independent review. That is about five times the 4.1% overturn rate across all services, so radiology practices that skip appeals are leaving recoverable revenue behind.
- What the study found: Of 9,160 advanced imaging denials reviewed by an independent review entity, 1,878 were overturned.
- Highest rates: MRI and CT angiography denials were overturned about 23% of the time, CT about 21% and PET about 17%.
- What it means: Imaging denials are far more contestable than most, and a disciplined appeals process turns that into recovered revenue.
What the SIIM-CAIMI Study Found
On October 27, 2026, AuntMinnie reported on a poster study presented at the Society for Imaging Informatics in Medicine (SIIM) CAIMI 2026 meeting in Philadelphia. A team led by James Tyler Ng of Geisinger Commonwealth School of Medicine analyzed Medicare Advantage prior authorization denials for advanced imaging, including CT, MRI, PET and CT angiography, that went through independent review entity (IRE) review.
The study included 9,160 advanced imaging prior authorization denials. At the IRE level, 20.5% were overturned, compared with 4.1% of denials across all services. That corresponds to a risk ratio of 4.98, meaning imaging denials were overturned about five times as often. The team compared imaging against 378,538 denials across all services and 367,192 non-imaging denials.
The volume of these cases is growing. According to the AuntMinnie report, IRE-decided imaging appeals rose from about 1,400 to more than 2,000 a year over the five-year study period, while the overturn rate held relatively steady, ranging from 16.0% to 22.7% in most years. Medicare Advantage insurers made about 53 million prior authorization determinations in a single recent year, and they increasingly use algorithmic utilization management tools to make them.
The researchers were careful about limits. They described IRE cases as “doubly selected,” because few denials are appealed at all and most successful appeals are resolved earlier, at the plan level. Their results do not generalize to every denial. They called for mandatory service-level reporting of Medicare Advantage prior authorization outcomes and independent evaluation of the algorithms used to decide advanced imaging requests.
Which radiology practices does this affect?
Any radiology group, imaging center or hospital outpatient department that performs CT, MRI, PET or CT angiography for Medicare Advantage patients is affected. Practices with high Medicare Advantage volume, limited staff for appeals or heavy reliance on radiology benefit managers carry the most denied revenue at risk.
The modality breakdown matters for planning. In the study, MRI denials were overturned 673 times out of 2,928 appeals, CT 699 out of 3,319, PET 421 out of 2,543 and CT angiography 85 out of 370. Practices with large MRI and CT volumes, such as those billing lumbar spine MRI under CPT 72148 or CT abdomen and pelvis under CPT 74177, have the most appeal opportunities.
Ownership structure changes who does the work. In a global billing arrangement, the imaging center or practice usually owns both the authorization and the appeal. In split billing, the facility typically handles prior authorization for the technical component, while the radiology group bills the professional component and can still be left unpaid when the study was never authorized. When a diagnostic study is denied, follow-up imaging and procedures that depend on it can be delayed too, so a single denial can affect more revenue than the one claim.
The most common issue we see providers run into is treating a prior authorization denial as final. Many practices reschedule, cancel or perform the study and write off the claim, never realizing the denial had a reasonable chance of being reversed.
Why Imaging Denials Get Overturned More Often
The study did not test causes, but its findings line up with patterns radiology billing teams see every day. Advanced imaging requests are often decided by algorithms or reviewers applying rigid criteria, such as requiring a specific number of weeks of conservative treatment before MRI. When a full clinical picture reaches an independent reviewer, the medical necessity case is frequently clearer than the initial review suggested.
The researchers specifically raised concerns about algorithmic utilization management. With tens of millions of prior authorization determinations a year, insurers rely on automated tools to screen requests, and those tools may deny requests that a human reviewer with complete records would approve. The study team recommended that algorithms used for imaging decisions face the same pre-deployment testing and post-deployment monitoring expected of diagnostic AI tools. We covered related payer scrutiny of automation in our post on AI in radiology billing.
Process rules also shape outcomes. Under CMS’s interoperability and prior authorization final rule, impacted payers have had to issue standard prior authorization decisions within seven calendar days and expedited decisions within 72 hours since January 1, 2026. Those deadlines make complete documentation on the first submission more important than ever.
Payer policies keep shifting at the same time. Some plans are reducing imaging prior authorization in certain areas, as we covered in our posts on UnitedHealthcare radiology prior authorization changes and its pediatric imaging prior authorization update, while others are tightening criteria. Practices need an appeals process that works regardless of which direction a given payer moves.
How much revenue could imaging prior auth appeals recover?
Recovery depends on denial volume and study value, but even conservative assumptions add up. Because advanced imaging denials are overturned at independent review about one in five times, a practice that systematically appeals instead of writing off denials can recover thousands of dollars a month.
Here is an illustrative example using round numbers, not reported data. Picture an imaging center that receives 40 Medicare Advantage prior authorization denials a month for CT and MRI, at an average allowed amount of $350 per study. That is $14,000 a month in denied revenue, or $168,000 a year. Applying only the 20.5% second-level overturn rate from the study, appeals would recover about $2,870 a month, or roughly $34,440 a year, before counting denials reversed earlier at the plan level. A multi-site group with four times that denial volume would be looking at roughly $138,000 a year in second-level recoveries alone under the same assumptions. Appeals also take staff time, so the goal is to prioritize the highest-value studies and payers first.
| Modality | Denials Reviewed by IRE | Overturned | Overturn Rate |
| MRI | 2,928 | 673 | 23.0% |
| CT angiography | 370 | 85 | 23.0% |
| CT | 3,319 | 699 | 21.1% |
| PET | 2,543 | 421 | 16.6% |
| All advanced imaging | 9,160 | 1,878 | 20.5% |
| All services | 378,538 | 15,569 | 4.1% |
In our experience matching radiology providers with billing partners, the practices that recover this revenue are the ones whose billing team tracks every prior authorization denial to a decision, rather than letting them disappear into a rescheduling queue.
Stop writing off imaging denials that could be overturned. Compare radiology billing companies that handle prior authorization, appeals and denial management, free, with rates starting as low as 2.95%.
How to Build an Imaging Appeals Process
A repeatable process is what separates practices that recover denied imaging revenue from those that absorb it.
- Log every prior authorization denial. Record the payer, modality, CPT code, denial reason and date for each denial in one tracker.
- Request the denial rationale. Ask for the specific clinical criteria the plan applied so the appeal answers the exact gap.
- Request a peer-to-peer review. Have the ordering physician speak with the plan’s reviewer when the plan allows it.
- Build a complete clinical packet. Include prior imaging, failed conservative treatment, symptoms, exam findings and the ordering physician’s rationale.
- File the plan-level reconsideration on time. Track each payer’s appeal deadline so no case is lost to a missed window.
- Follow the case to independent review. When a Medicare Advantage plan upholds its denial at reconsideration, confirm the case is forwarded to the independent review entity.
- Measure results by payer and modality. Track overturn rates to target the payers and study types where appeals pay off most.
Many overturned denials trace back to documentation gaps that also cause claim denials, so the same process improves front-end authorization requests over time. Assign one owner for the tracker so no denial sits without action, and review approaching deadlines weekly. Template appeal letters by modality and denial reason, such as missing conservative therapy or no prior imaging, cut drafting time while still letting the clinical details of each case carry the argument.
Common Mistakes With Imaging Prior Auth Denials
The most costly mistake is not appealing. The study’s authors noted that few denials are appealed at all, which means most practices never test whether a denial would have held up. Every unappealed denial is a guaranteed loss.
The second mistake is sending a thin appeal. A one-page letter restating the order rarely changes a decision. Successful imaging appeals answer the plan’s specific criteria with clinical evidence, such as documented weeks of conservative therapy or red-flag symptoms that justify immediate imaging.
The third mistake is performing the study and hoping for retroactive approval. Retroactive authorization is often limited or unavailable, so performing a denied study without a plan can leave the practice with no path to payment for the technical or professional component.
The fourth mistake is ignoring coding alignment. An authorization approved for one CPT code does not cover a different code, such as a study with contrast when the approval was for without contrast. Coding mismatches cause denials that have nothing to do with medical necessity. Our guide to CPT 71250 for chest CT without contrast shows how specific those distinctions get.
The last mistake is not measuring. Without tracking overturn rates by payer and modality, practices cannot tell where appeals are worth the effort or which front-end fixes would prevent denials. Denials that go unworked are a major source of the revenue leakage we see in radiology billing. Reviewing those numbers monthly keeps the appeals effort focused where it pays.
In-House Appeals vs. Outsourced Denial Management
Appeals take time that most radiology front offices do not have. Each case requires pulling records, coordinating with ordering physicians, writing a clinical argument and tracking deadlines across multiple payers and radiology benefit managers. When staff are busy scheduling and authorizing new studies, appeals slip.
That is where Radiology Bill Co helps. We are part of Billing Service Quotes, a free matching platform, not a billing company. You submit a short request, our team uses a human review to match you with billing companies in our network that fit your modalities, volume and software, and you are typically connected within 30 minutes. Tim Daniels, Director of Strategic Accounts, and our team work with practices across more than 60 specialties in all 50 states, and we have matched about 2,000 providers.
Billing companies in our network offer revenue cycle management, prior authorization support, denial management, credentialing and HIPAA compliance support, and many are software agnostic, so they can work inside your existing RIS, PACS or EHR. Rates start as low as 2.95%, depending on practice size and specialty. Outsourcing also brings pattern knowledge a single practice rarely has. A billing team that works imaging denials across many payers learns which criteria each plan applies, which documentation tends to win and where peer-to-peer requests are worth the effort, which shortens the path from denial to decision.
To see how matching works for imaging practices, visit the Radiology Bill Co home page.
Frequently Asked Questions
A study presented at SIIM-CAIMI 2026 found that 20.5% of Medicare Advantage prior authorization denials for advanced imaging were overturned at independent review, compared with 4.1% across all services. MRI and CT angiography denials had the highest overturn rates, at about 23% each.
An independent review entity is the outside organization that reviews Medicare Advantage denials a plan has upheld at its own reconsideration level. It is the second level of appeal and is independent of the plan, which is why its decisions offer the only public data naming specific denied services under appeal.
Request the plan’s denial rationale, ask for a peer-to-peer review, and file a reconsideration with complete clinical documentation, including prior imaging, conservative treatment history and the ordering physician’s reasoning. If the Medicare Advantage plan upholds the denial, the case moves to independent review.
The study did not test causes, but its authors raised concerns about algorithmic utilization management in prior authorization decisions. When complete clinical records reach an independent reviewer, medical necessity for advanced imaging is often clearer than the initial automated or criteria-based review suggested.
Under CMS’s interoperability and prior authorization final rule, impacted payers must issue standard prior authorization decisions within seven calendar days and expedited decisions within 72 hours. Those timeframes have applied since January 1, 2026. Expedited decisions apply when waiting could seriously jeopardize the patient’s health.
Yes. Many billing companies in the Radiology Bill Co network handle prior authorization support, appeals and denial management alongside claims. Through our free matching service, you can compare companies that work with imaging practices, with rates starting as low as 2.95%.
Next Steps
- Review how one major payer is changing imaging authorization in our post on UnitedHealthcare radiology prior authorization.
- Find the coding details behind common denials in our CPT 72148 lumbar spine MRI guide.
- Learn where else imaging revenue slips away in our post on radiology billing gaps and revenue leakage.
Recover the imaging revenue you are losing to denials. Compare radiology billing companies free and get matched in 30 minutes.